Exportar este item: EndNote BibTex

Use este identificador para citar ou linkar para este item: http://tede.ucpel.edu.br:8080/jspui/handle/tede/271
Registro completo de metadados
Campo DCValorIdioma
dc.creatorGodoi, Gabriela Loreapt_BR
dc.creator.Latteshttp://lattes.cnpq.br/4379872893402187por
dc.contributor.advisor1Almeida Jr, Hiram Larangeira dept_BR
dc.contributor.advisor1Lattesnpor
dc.date.accessioned2016-03-22T17:26:57Z-
dc.date.available2013-10-04pt_BR
dc.date.issued2007-12-15pt_BR
dc.identifier.citationGODOI, Gabriela Lorea. Selenium compounds prevent amyloid-beta peptide neurotoxicity in rat primary hippocampal neurons. 2007. 83 f. Dissertação (Mestrado em saúde) - Universidade Catolica de Pelotas, Pelotas, 2007.por
dc.identifier.urihttp://tede.ucpel.edu.br:8080/jspui/handle/tede/271-
dc.description.resumo.por
dc.description.abstractAlzheimer s disease (AD) is the most common form of dementia among elder. Neuropathological hallmarks include amyloid plaque formation, neurofibrillary tangles, neuronal and synaptic loss. The deposit of senile plaques is consistent with induction of oxidative stress, and since free radical scavengers can alleviate amyloid-beta-induced oxidative stress markers, this study aims to identify the neuroprotective effects of the selenium compounds (ebselen and diphenyl diselenide) on the neurotoxicity of amyloid-beta in primary cultures of murine hippocampal neurons. Samples were subjected to immunocytochemistry and western blotting techniques to determine what influence the treatments may have on synaptic protein SNAP-25 and neuronal death. There was a strong increase in relative cell viability associated with ebselen and diphenyl diselenide treatment. Significant increases were observed in the level of synaptic marker synaptosomal-associated protein SNAP-25 with both selenium compounds treatment. Although demonstrated the potential protective effect of selenium compounds in the course of AD, further investigations of synaptic function are important as a therapeutic strategy for ADeng
dc.description.provenanceMade available in DSpace on 2016-03-22T17:26:57Z (GMT). No. of bitstreams: 1 Gabriela Lorea Godoi.pdf: 2588661 bytes, checksum: 727e9c41458c3dce6b21674525afb233 (MD5) Previous issue date: 2007-12-15eng
dc.formatapplication/pdfpor
dc.thumbnail.urlhttp://tede.ucpel.edu.br:8080/jspui/retrieve/1504/Gabriela%20Lorea%20Godoi.pdf.jpg*
dc.languageporpor
dc.publisherUniversidade Catolica de Pelotaspor
dc.publisher.departmentsaúdepor
dc.publisher.countryBRpor
dc.publisher.initialsUcpelpor
dc.publisher.programMestrado em Saúde e Comportamentopor
dc.rightsAcesso Abertopor
dc.subjectalzheimerpor
dc.subjectbeta amilóidepor
dc.subjectebselenpor
dc.subjectdisselenetopor
dc.subjecthipocampopor
dc.subjectAlzheimer diseaseeng
dc.subjectebseleneng
dc.subjectdiphenyl diselenideeng
dc.subjectamyloid-beta peptideeng
dc.subject.cnpqCNPQ::CIENCIAS DA SAUDE::MEDICINApor
dc.titleEfeito dos compostos orgânicos de selênio - ebselen e disseleneto de difenila - na morte neuronal causada pelo peptídeo beta-amilóide em culturas primárias de neurônio de hipocampo de ratopor
dc.title.alternativeSelenium compounds prevent amyloid-beta peptide neurotoxicity in rat primary hippocampal neuronseng
dc.typeDissertaçãopor
Aparece nas coleções:Biblioteca Digital de Teses e Dissertações

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Gabriela Lorea Godoi.pdf2,53 MBAdobe PDFThumbnail

Baixar/Abrir Pré-Visualizar


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.